NCT06096779 2026-04-03
Kirros
Genentech, Inc.
Phase 2 Recruiting
Clinical Trials
83 trialsNCT06600321 2026-03-31
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT07377487 2026-03-30
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT05063565 2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT07010315 2026-03-04
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT06523608 2025-12-22
DETECT
University Hospital Muenster
Recruiting
NCT04618692 2025-12-18
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
Phase NA Completed
NCT07191548 2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA Not yet recruiting
NCT04539717 2025-10-08
FAST (Focused Abbreviated Screening Technique)-MRI Study
Icahn School of Medicine at Mount Sinai
Enrolling by invitation
NCT04727307 2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2 Recruiting
NCT07111130 2025-09-23
RE-BALANCE
National Cancer Centre, Singapore
Phase NA Not yet recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - HĂ´pitaux de Paris
Phase NA Not yet recruiting
NCT04525833 2025-09-19
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Recruiting
NCT07150624 2025-09-02
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Phase 4 Recruiting
NCT02312817 2025-07-15
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
Phase NA Completed
NCT07053488 2025-07-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT04965259 2025-07-02
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
National Cancer Centre, Singapore
Active not recruiting
NCT02908048 2025-04-06
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Active not recruiting
NCT05233098 2025-03-06
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Completed
NCT04926376 2024-11-29
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
ABK Biomedical
Phase NA Completed
NCT05817994 2024-11-19
REGAL
Sheikh Shakhbout Medical City
Withdrawn
NCT06061276 2024-09-23
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Sun Yat-sen University
Phase NA Recruiting
NCT02301104 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT06070636 2024-08-09
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Recruiting
NCT05931068 2024-08-05
PRO-NRG
Academisch Ziekenhuis Maastricht
Recruiting
NCT05053412 2024-08-02
HEPATIC
Helio Genomics
Completed
NCT06501742 2024-07-15
HMCV
University Hospital, Strasbourg, France
Recruiting
NCT04518852 2024-06-25
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
Phase 2 Completed
NCT02508467 2024-04-12
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Blueprint Medicines Corporation
Phase 1 Completed
NCT04627012 2024-03-06
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Completed
NCT05471596 2024-03-04
MWA
Wake Forest University Health Sciences
Completed
NCT05184283 2023-12-07
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Terminated
NCT02337673 2023-09-29
Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Johannes Gutenberg University Mainz
Completed
NCT01390194 2023-09-06
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
University of Nebraska
Completed
NCT05723705 2023-03-27
LIVEROBOT
Amsterdam UMC, location VUmc
Unknown
NCT04172714 2022-12-06
Low-dose Y90 Treatment Planning for HCC
Emory University
Phase NA Completed
NCT02960620 2022-09-28
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
H. Lee Moffitt Cancer Center and Research Institute
No longer available
NCT04375670 2022-08-09
COVID19-FOIE National Observatory
Assistance Publique - HĂ´pitaux de Paris
Completed
NCT03396705 2022-04-07
Liver Regeneration
University Health Network, Toronto
Terminated
NCT04825470 2022-03-11
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Phase NA Unknown
NCT04190849 2022-03-04
EU-PNAFLD
Cambridge University Hospitals NHS Foundation Trust
Recruiting
NCT02292173 2021-06-10
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00543777 2021-04-13
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03405909 2021-03-02
ESCULAP
University Hospital Erlangen
Completed
NCT03008512 2021-02-04
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib
Gachon University Gil Medical Center
Phase 2 Terminated
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown